Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Candidatus Mycoplasma haematominutum 'Birmingham 1'

ABSTRACT: Candidatus Mycoplasma haemominutum Birmingham 1 Genome Sequencing

PROVIDER: PRJNA76933 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Candidatus Mycoplasma haematominutum

Project description:Candidatus Mycoplasma haemominutum overview

| PRJNA77709 | ENA

Candidatus Mycoplasma haematolamae

Project description:Candidatus Mycoplasma haemolamae overview

| PRJNA68393 | ENA

Candidatus Mycoplasma haematolamae str. Purdue

Project description:Candidatus Mycoplasma haematolamae str. Purdue Genome sequencing

| PRJNA68151 | ENA

Candidatus Mycoplasma mahonii strain:OP267

Project description:Candidatus Mycoplasma mahonii strain:OP267 Genome sequencing

| PRJNA912223 | ENA

Candidatus Mycoplasma haematobovis strain:INIFAP01

Project description:Candidatus Mycoplasma haemobos strain:INIFAP01 Genome sequencing and assembly

| PRJNA319681 | ENA

microRNA identification in the Mycoplasma bovis infected mammary gland tissue in Holstein Friesian cattle

Project description:The immune response associated with mastitis caused by Mycoplasma bovis is a very complicated biological process in several type of cells, including immune cells, mammary epithelial cells and, endothelial cells. Thus, revealing of the microRNAs in the Mycoplasma bovis infected mammary gland tissues is particularly important for the immune response mechanism to Mycoplasma bovis. Firstly, mammary gland tissue samples were collected from Holstein cows and screened for Mycoplasma bovis. Then, total RNA was isolated from mycoplasma bovis infected tissues and RNA sequencing was performed. After bioinformatics analysis, GO and KEGG analysis of target genes of identified microRNAs were conducted. Our results revaled that 24 of the known microRNAs were expressed differently and 13 of the novel microRNAs were expressed differently in Mycoplasma bovis positive tissues. The target genes of these microRNAs were found to be associated with especially inflammation pathways. In conclusion, this study demonstrated that identified miRNAs may be involved in the signaling pathways during mastitis case caused by Mycoplasma bovis.

2021-05-25 | GSE152865 | GEO

Biosafety circuits for Mycoplasma - DNA-seq for passages 2, 3 and 15 of clonal Mycoplasma pneumoniae biosafety strains to study long-term stability of kill-switch devices

Project description:We have engineered synthetic gene switches to control and limit Mycoplasma growth for biosafety containment applications. Mycoplasmas have high mutation rates and, the accumulation of mutations that inactivate the circuit is expected. However, the question is how resilient is the kill-switch to mutation and whether it is more sensitive to the accumulation of mutations. Therefore, we did the whole-genome sequencing of the three Mycoplasma biosafety strains, designed in our study, at different passages (p2, p3 and p15) or after IPTG-treatment at passage 3 (p3IPTG)

2022-02-09 | E-MTAB-10981 | biostudies-arrayexpress

Mycoplasma

Project description:Mycoplasma Genome sequencing

| PRJNA970269 | ENA

Mycoplasma

Project description:Mycoplasma Genome sequencing

| PRJNA506155 | ENA

Transposon sequencing to identify random insertions of lox sites in Mycoplasma pneumoniae

Project description:This dataset was used to assess the random insertion by tranposases of lox sites in Mycoplasma pneumoniae. This is part of the protocol LoxTnSeq, a new methodology to generate and catalogue libraries of genome reduction mutants. LoxTnSeq combines random integration of Lox sites by transposon mutagenesis, and the generation of mutants via cre recombinase, catalogued via deep-sequencing. When LoxTnSeq was applied to the naturally genome reduced bacterium Mycoplasma pneumoniae, we obtained a mutant pool containing 285 unique deletions. These deletions spanned from >50 bp to 28 Kb, which represent 21% of the total genome. LoxTnSeq also highlighted large regions of non-essential genes that could be removed simultaneously, and other similar regions that could not, providing a guide for future genome reductions.

2021-08-18 | E-MTAB-9590 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data